A drug prescribed for Alzheimer's disease does not ease clinically significant agitation in patients, according to first randomized controlled trial designed to assess the effectiveness of the drug (generic name memantine) for significant agitation in Alzheimer's patients.
View post:
Alzheimer's drug ... continue reading
Four months before a best-selling Alzheimer's drug was set to lose its patent protection, its makers received approval for a higher dosage that extended their exclusive right to sell the drug. But the higher dosage caused potentially dangerous side effects and worked only slightly better than the existing drugs, according ... continue reading
People with Alzheimer's disease who continue taking the drug donepezil (Aricept) do get some benefit even as their symptoms worsen, a new study suggests.
More:
Hard to tell, but drug helps as Alzheimer's progresses
According to findings in a study published in PLoS One, a new drug candidate may be the first drug that is capable of halting the devastating mental decline of Alzheimer’s disease. Researchers administered the drug, known as J147, to mice with Alzheimer’s disease and observed an associated improvement in memory ... continue reading
Salk scientists develop new drug that improves memory and prevents brain damage in mice A new drug candidate may be the first capable of halting the devastating mental decline of Alzheimer’s disease, based on the findings of a study published Dec. 14 in PLoS ONE. When given to mice with ... continue reading